Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis for matched related donor hematopoietic stem cell transplantation in acute leukemia: a systematic review and meta-analysis

Although allogeneic hematopoietic stem cell transplantation (HSCT) offers curative potential for acute leukemia, graft-versus-host disease (GVHD) remains a major obstacle to optimal clinical outcomes. Evidence for post-transplant cyclophosphamide (PTCy) in the matched related donor (MRD) setting is...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Amirhossein Shahsavand, Shayan Forghani, Reza Samiee, Mohammad Amin Kharaghani, Ghasem Janbabai, Zahra Salehi, Tahereh Rostami
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Taylor & Francis Group 2026-12-01
Rangatū:	Hematology
Ngā marau:	post-transplant cyclophosphamide (PTCy) matched related donor (MRD) graft-versus-host disease (GvHD) acute leukemia systematic review meta-analysis
Urunga tuihono:	https://www.tandfonline.com/doi/10.1080/16078454.2026.2631227
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!